AKT is an important target and prognostic marker in prostate cancer and signification overexpression of AKT1, AKT2 and mTOR genes was observed in human prostate cancer samples compared with normal prostate gland tissue (91, 92). This evidence concerns the gene AKT2 and prostate carcinoma.